The nation’s top drug regulator, Richard Pazdur, has decided to retire three weeks after taking the job, according to two people familiar with his decision who spoke on the condition of anonymity to ...

Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating ...

Longtime FDA oncology leader and newly appointed Center for Drug Evaluation and Research director Richard Pazdur has filed ...

Richard Pazdur, the US Food and Drug Administration’s lead drug regulator, plans to retire from the agency only weeks after starting his new role, in a major setback for Commissioner Marty Makary.

Food and Drug Administration chief Marty Makary convinced Rick Pazdur to take the role to help bring stability to the roiling agency.

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...

Kirk Milhoan has claimed without evidence that the covid-19 shots caused spikes in cancer and miscarriages. Now he's helping ...

A confidential internal memo from the U.S. Food and Drug Administration (FDA) is creating new controversy around vaccine ...

The three-dose hepatitis B vaccine has a long track record of safety, but rolling back recommendations could leave kids ...

With no evidence to support the claim that 10 children died due to COVID-19 vaccines, experts unpack the impact of CBER chief ...

The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard Pazdur, is set to ...